These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8840812)

  • 41. Treatment of bullous impetigo and the staphylococcal scalded skin syndrome in infants.
    Johnston GA
    Expert Rev Anti Infect Ther; 2004 Jun; 2(3):439-46. PubMed ID: 15482208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Staphylococcal scalded skin syndrome associated with long-term catherter related infection in an adult].
    Kutsuna S; Kasahara K; Nakagawa C; Komatsu Y; Katanami Y; Ogawa T; Uno K; Maeda K; Konishi M; Mikasa K
    Kansenshogaku Zasshi; 2013 May; 87(3):380-4. PubMed ID: 23819352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Staphylococcal scalded skin syndrome.
    Gemmell CG
    J Med Microbiol; 1995 Nov; 43(5):318-27. PubMed ID: 7562995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Staphylococcal toxin syndromes.
    Ginsburg CM
    Pediatr Infect Dis J; 1991 Apr; 10(4):319-21. PubMed ID: 2062629
    [No Abstract]   [Full Text] [Related]  

  • 45. Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases.
    Gravet A; Couppié P; Meunier O; Clyti E; Moreau B; Pradinaud R; Monteil H; Prévost G
    J Clin Microbiol; 2001 Dec; 39(12):4349-56. PubMed ID: 11724844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Staphylococcal toxins in human disease.
    Arbuthnott JP; Coleman DC; de Azavedo JS
    Soc Appl Bacteriol Symp Ser; 1990; 19():101S-107S. PubMed ID: 2119059
    [No Abstract]   [Full Text] [Related]  

  • 47. Two highly divergent lineages of exfoliative toxin B-encoding plasmids revealed in impetigo strains of Staphylococcus aureus.
    Botka T; Růžičková V; Svobodová K; Pantůček R; Petráš P; Čejková D; Doškař J
    Int J Med Microbiol; 2017 Sep; 307(6):291-296. PubMed ID: 28579477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kampo medicines suppress the production of exfoliative toxins causing impetigo in Staphylococcus aureus.
    Katayama I; Nakaminami H; Yamada T; Ikoshi H; Noguchi N
    J Dermatol; 2020 Jul; 47(7):714-719. PubMed ID: 32415796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel method for rapid production and purification of exfoliative toxin A of Staphylococcus aureus.
    Ladhani S; Cameron J; Chapple DS; Garratt RC; Joannou CL; Evans RW
    FEMS Microbiol Lett; 2002 Jun; 212(1):35-9. PubMed ID: 12076784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible receptor for exfoliative toxins produced by Staphylococcus hyicus and Staphylococcus aureus.
    Tanabe T; Sato H; Ueda K; Chihara H; Watanabe T; Nakano K; Saito H; Maehara N
    Infect Immun; 1995 Apr; 63(4):1591-4. PubMed ID: 7890427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Staphylococcal scalded skin syndrome in two immunocompetent adults caused by exfoliatin B-producing Staphylococcus aureus.
    Opal SM; Johnson-Winegar AD; Cross AS
    J Clin Microbiol; 1988 Jul; 26(7):1283-6. PubMed ID: 3137245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunological investigations on pathogenesis of staphylococcal scalded skin syndrome].
    Machida K
    Rinsho Byori; 1995 Jun; 43(6):547-56. PubMed ID: 7602798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cloning and expression of the exfoliative toxin B gene from Staphylococcus aureus.
    Jackson MP; Iandolo JJ
    J Bacteriol; 1986 May; 166(2):574-80. PubMed ID: 3009410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Staphylococcal scalded skin syndrome in an adult associated with methicillin-resistant Staphylococcus aureus.
    Acland KM; Darvay A; Griffin C; Aali SA; Russell-Jones R
    Br J Dermatol; 1999 Mar; 140(3):518-20. PubMed ID: 10233278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional evidence that the Ser-195 residue of staphylococcal exfoliative toxin A is essential for biological activity.
    Prévost G; Rifai S; Chaix ML; Piémont Y
    Infect Immun; 1991 Sep; 59(9):3337-9. PubMed ID: 1908832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Staphylococcal scalded-skin syndrome in an adult due to methicillin-resistant Staphylococcus aureus.
    Ito Y; Funabashi Yoh M; Toda K; Shimazaki M; Nakamura T; Morita E
    J Infect Chemother; 2002 Sep; 8(3):256-61. PubMed ID: 12373491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiological investigation of exfoliative toxin-producing Staphylococcus aureus strains in hospitalized patients.
    Piemont Y; Rasoamananjara D; Fouace JM; Bruce T
    J Clin Microbiol; 1984 Mar; 19(3):417-20. PubMed ID: 6232283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of blister formation by staphylococcal toxins.
    Hanakawa Y; Stanley JR
    J Biochem; 2004 Dec; 136(6):747-50. PubMed ID: 15671483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic diversity of two lineages of exfoliative toxin A-converting phages predominating in Staphylococcus aureus strains in the Czech Republic.
    Holochová P; Růzicková V; Pantůcek R; Petrás P; Janisch R; Doskar J
    Res Microbiol; 2010 May; 161(4):260-7. PubMed ID: 20382218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutational analysis of the superantigen staphylococcal exfoliative toxin A (ETA).
    Rago JV; Vath GM; Bohach GA; Ohlendorf DH; Schlievert PM
    J Immunol; 2000 Feb; 164(4):2207-13. PubMed ID: 10657676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.